Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1983 Oct;198(4):546–553. doi: 10.1097/00000658-198310000-00015

Resection of gastrinomas.

C W Deveney, K E Deveney, D Stark, A Moss, S Stein, L W Way
PMCID: PMC1353204  PMID: 6138003

Abstract

Exploratory laparotomy and a search for gastrinomas was performed in 52 patients with the Zollinger-Ellison syndrome (ZES). Gastrinoma tissue was resected in 11 patients (21%), 6 (12%) of whom appear to have been cured. After surgery, serum gastrin levels in these six patients have remained normal from 10 months to 10 years. In the 46 other patients, tumor was unresectable because of metastases or multiple primary tumors (21 patients; 40%) or inability to find the tumor at laparotomy (21 patients; 40%). Multiple pancreatic islet cell adenomata were found in six of seven patients with multiple endocrine neoplasia (MEN), indicating that patients with this condition usually have diffuse involvement of the pancreas. The results of CT scans correlated with findings at laparotomy in 13 of 16 patients. The smallest tumor detected by CT scans was 1 cm in diameter. CT technology is more accurate in finding gastrinomas now than in the past and has a useful role in preoperative evaluation. The possibility of resection should be seriously considered in every patient with Zollinger-Ellison syndrome. Abdominal CT scans, transhepatic portal venous sampling, and laparotomy should be used to find the tumor and to determine whether it is resectable. Using presently available methods, it should be possible to cure about 25% of patients with gastrinomas who do not have MEN and over 70% of those without MEN who appear to have a solitary tumor. Total pancreatectomy may be necessary to cure some patients with MEN, but that operation is rarely justified. The morbidity and mortality of surgical attempts at curing this disease have become minimal; we have had no deaths or serious complications following such operations in over 10 yrs. Total gastrectomy and indefinite use of H2-receptor blocking agents are the therapeutic options for patients with unresectable gastrinomas. Because H2-receptor blocking agents fail to control acid secretion in many patients after several yrs of therapy, total gastrectomy is indicated in a large proportion of patients whose tumors cannot be resected. Total gastrectomy in patients with ZES is also safe using current techniques; our last death following this operation for ZES occurred 15 yrs ago.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barreras R. F., Mack E., Goodfriend T., Damm M. Resection of gastrinoma in the Zollinger-Ellison syndrome. Gastroenterology. 1982 May;82(5 Pt 1):953–956. [PubMed] [Google Scholar]
  2. Bonfils S., Landor J. H., Mignon M., Hervoir P. Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg. 1981 Dec;194(6):692–697. doi: 10.1097/00000658-198112000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burcharth F., Stage J. G., Stadil F., Jensen L. I., Fischermann K. Localization of gastrinomas by transhepatic portal catheterization and gastrin assay. Gastroenterology. 1979 Sep;77(3):444–450. [PubMed] [Google Scholar]
  4. Damgaard-Petersen K., Stage J. G. CT scanning in patients with Zollinger-Ellison syndrome and carcinoid syndrome. Scand J Gastroenterol Suppl. 1979;53:117–122. [PubMed] [Google Scholar]
  5. Deveney C. W., Deveney K. S., Jaffe B. M., Jones R. S., Way L. W. Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome). Ann Intern Med. 1977 Dec;87(6):680–686. doi: 10.7326/0003-4819-87-6-680. [DOI] [PubMed] [Google Scholar]
  6. Deveney C. W., Deveney K. S., Way L. W. The Zollinger-Ellison syndrome--23 years later. Ann Surg. 1978 Sep;188(3):384–393. doi: 10.1097/00000658-197809000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deveney C. W., Stein S., Way L. W. Cimetidine in the treatment of Zollinger-Ellison syndrome. Am J Surg. 1983 Jul;146(1):116–123. doi: 10.1016/0002-9610(83)90271-4. [DOI] [PubMed] [Google Scholar]
  8. Dunnick N. R., Doppman J. L., Mills S. R., McCarthy D. M. Computed tomographic detection of nonbeta pancreatic islet cell tumors. Radiology. 1980 Apr;135(1):117–120. doi: 10.1148/radiology.135.1.6244605. [DOI] [PubMed] [Google Scholar]
  9. ELLISON E. H., WILSON S. D. THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES. Ann Surg. 1964 Sep;160:512–530. doi: 10.1097/00000658-196409000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fox P. S., Hofmann J. W., Decosse J. J., Wilson S. D. The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors. Ann Surg. 1974 Oct;180(4):558–566. doi: 10.1097/00000658-197410000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Friesen S. R. Treatment of the Zollinger-Ellison syndrome. A 25 year assessment. Am J Surg. 1982 Mar;143(3):331–338. doi: 10.1016/0002-9610(82)90102-7. [DOI] [PubMed] [Google Scholar]
  12. Glowniak J. V., Shapiro B., Vinik A. I., Glaser B., Thompson N. W., Cho K. J. Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction. N Engl J Med. 1982 Jul 29;307(5):293–297. doi: 10.1056/NEJM198207293070507. [DOI] [PubMed] [Google Scholar]
  13. Hofmann J. W., Fox P. S., Wilson S. D. Duodenal wall tumors and the Zollinger-Ellison syndrome. Surgical management. Arch Surg. 1973 Aug;107(2):334–339. doi: 10.1001/archsurg.1973.01350200194040. [DOI] [PubMed] [Google Scholar]
  14. Isenberg J. I., Walsh J. H., Grossman M. I. Zollinger-Ellison syndrome. Gastroenterology. 1973 Jul;65(1):140–165. [PubMed] [Google Scholar]
  15. Jensen R. T., Gardner J. D., Raufman J. P., Pandol S. J., Doppman J. L., Collen M. J. Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med. 1983 Jan;98(1):59–75. doi: 10.7326/0003-4819-98-1-59. [DOI] [PubMed] [Google Scholar]
  16. McCarthy D. M. The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med. 1980 Jun 12;302(24):1344–1347. doi: 10.1056/NEJM198006123022404. [DOI] [PubMed] [Google Scholar]
  17. Modlin I. M., Jaffe B. M., Sank A., Albert D. The early diagnosis of gastrinoma. Ann Surg. 1982 Nov;196(5):512–517. doi: 10.1097/00000658-198211000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Oberhelman H. A., Jr Excisional therapy for ulcerogenic tumors of the duodenum: long-term results. Arch Surg. 1972 Apr;104(4):447–453. doi: 10.1001/archsurg.1972.04180040061011. [DOI] [PubMed] [Google Scholar]
  19. Parrish J. A., Rawlins D. C. Intestinal mucosa in the Zollinger-Ellison syndrome. Gut. 1965 Jun;6(3):286–289. doi: 10.1136/gut.6.3.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. RAWSON A. B., ENGLAND M. T., GILLAM G. G., FRENCH J. M., STAMMERS F. A. Zollinger-Ellison syndrome with diarrhoea and malabsorption. Observations on a patient before and after pancreatic islet-cell tumour removal with-out resort. Lancet. 1960 Jul 16;2(7142):131–134. doi: 10.1016/s0140-6736(60)91271-x. [DOI] [PubMed] [Google Scholar]
  21. Roche A., Raisonnier A., Gillon-Savouret M. C. Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases. Radiology. 1982 Dec;145(3):621–627. doi: 10.1148/radiology.145.3.6292994. [DOI] [PubMed] [Google Scholar]
  22. Way L., Goldman L., Dunphy J. E. Zollinger-Ellison syndrome. An analysis of twenty-five cases. Am J Surg. 1968 Aug;116(2):293–304. doi: 10.1016/0002-9610(68)90507-2. [DOI] [PubMed] [Google Scholar]
  23. Zollinger R. M., Ellison E. C., Fabri P. J., Johnson J., Sparks J., Carey L. C. Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal. Ann Surg. 1980 Sep;192(3):422–430. doi: 10.1097/00000658-198009000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES